Astec LifeSciences Limited (ASTEC.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.58B |
| Enterprise Value | 15.96B |
| P/E Ratio | -19.88 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 3.04 |
| Price/Book Ratio | 3.43 |
| Enterprise/Revenue | 3.04 |
| Enterprise/EBITDA | 149.15 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.15 |
| Operating Margin | -0.09 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | -0.17 |
Income Statement
| Revenue | 4.48B |
| Revenue/Share | 197.75 |
| Gross Profit | 419.01M |
| EBITDA | -15.49M |
| Net Income | -809.18M |
| Diluted EPS | -37.79 |
Balance Sheet
| Total Cash | 100.49M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 175.44 |
Price History
| 52-Week Change | -33.31 |
| 52-Week High | 941.75 |
| 52-Week Low | 513.4 |
| Moving Average 50 Days | 680.35 |
| Moving Average 200 Days | 677.46 |
Statistics
| Average Volume | 65,575 |
| Shares Outstanding | 22.28M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
